FindTrial
Sign In

Role of pulmonary fibroblasts in the injury repair of chronic obstructive pulmonary disease

Role of versican1 in tissure repair by lung fibroblasts in chronic obstructive pulmonary disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OCC-10000781
Enrollment
Unknown
Registered
2010-02-11
Start date
2010-02-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic obstructive pulmonary disease

Interventions

COPD group:To get tissue from peripheral areas of the lung tissue from operation due to lung cancer
non-COPD group:To get tissue from peripheral areas of the lung tissue from operation due to lung cancer

Sponsors

Zhongshan Hospital, Fudan Universitiy
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Subjects who are diagnosed as COPD according to the guideline for the management of COPD released in 2004 by Chinese respiratory society; 2. Able and willing to provide signed informed consent.

Exclusion criteria

Exclusion criteria: Subjects with tuberculosis, tumor (except for lung cancer), diabetes, or chronic diseases such as liver or renal function impairment.

Design outcomes

Primary

MeasureTime frame
function of lung fibroblast;—

Countries

China

Contacts

Public ContactJing Zhang
zhang.jing@zs-hospital.sh.cn+86 21 64041990

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026